Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
No edit summary
No edit summary
Line 5: Line 5:
!Author Content (Pending or Complete)
!Author Content (Pending or Complete)
!Editor Reviewed (Date)
!Editor Reviewed (Date)
!Notes
|-
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''|| ||Fabiola Quintero-Rivera (FQR)
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''|| ||Fabiola Quintero-Rivera (FQR)
|
|
|
|
|
Line 12: Line 14:
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
| ||FQR
| ||FQR
|
|
|
|
|
Line 17: Line 20:
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
| ||FQR
| ||FQR
|
|
|
|
|
Line 22: Line 26:
|    Polycythaemia Vera  (PV)||Disease
|    Polycythaemia Vera  (PV)||Disease
| ||FQR
| ||FQR
|
|
|
|
|
Line 27: Line 32:
|    Primary Myelofibrosis  (PMF)||Disease
|    Primary Myelofibrosis  (PMF)||Disease
| ||FQR
| ||FQR
|
|
|
|
|
Line 32: Line 38:
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
| ||FQR
| ||FQR
|
|
|
|
|
Line 37: Line 44:
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
| ||FQR
| ||FQR
|
|
|
|
|
Line 42: Line 50:
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
| ||FQR
| ||FQR
|
|
|
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
|
|
|
|
|
Line 51: Line 61:
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
| ||FQR
| ||FQR
|
|
|
|
|
Line 56: Line 67:
|    Systemic Mastocytosis||Disease
|    Systemic Mastocytosis||Disease
| ||FQR
| ||FQR
|
|
|
|
|
Line 61: Line 73:
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
| ||FQR
| ||FQR
|
|
|
|
|
|-
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''|| ||FQR
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''|| ||FQR
|
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR
|
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR
|
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR
|
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease|| ||FQR
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease|| ||FQR
|
|
|
|
|
|-
|-
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''|| ||FQR
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''|| ||FQR
|
|
|
|
|
|-
|-
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease|| ||FQR
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease|| ||FQR
|
|
|
|
|
|-
|-
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease|| ||FQR
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease|| ||FQR
|
|
|
|
|
|-
|-
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease|| ||FQR
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease|| ||FQR
|
|
|
|
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease|| ||FQR
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease|| ||FQR
|
|
|
|
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR
|
|
|
|
|
|-
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR
|
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease|| ||FQR
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease|| ||FQR
|
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease|| ||FQR
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease|| ||FQR
|
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease|| ||FQR
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease|| ||FQR
|
|
|
|
|
|-
|-
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease|| ||FQR
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease|| ||FQR
|
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease|| ||FQR
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease|| ||FQR
|
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease|| ||FQR
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease|| ||FQR
|
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease|| ||FQR
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease|| ||FQR
|
|
|
|
|
|-
|-
|    Refractory Cytopenia  of Childhood||Disease|| ||FQR
|    Refractory Cytopenia  of Childhood||Disease|| ||FQR
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
Line 151: Line 185:
|Jennelle Hodge (JH)
|Jennelle Hodge (JH)
|Complete
|Complete
|
|
|
|-
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou ||JH
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou||JH
|
|
|
|
|
|-
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH
|
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang||JH
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang||JH
|
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori||JH
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori||JH
|
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang||JH
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang||JH
|
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou ||JH
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou||JH
|
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+Path Resident||JH
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+Path Resident||JH
|
|
|
|
|
Line 184: Line 226:
|JH
|JH
|Complete
|Complete
|
|
|
|-
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH
|
|
|
|
|
|-
|-
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty||JH
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty||JH
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng  Choy via Greg Conboy (Monash Health)||JH
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng  Choy via Greg Conboy (Monash Health)||JH
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg  Conboy (Monash Health)||JH
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg  Conboy (Monash Health)||JH
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Path Resident  (Iris Martin)||JH
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Path Resident  (Iris Martin)||JH
|
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH
|
|
|
|
|
|-
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH
|
|
|
|
|
|-
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar  Iqbal||JH
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar  Iqbal||JH
|
|
|
|
|
|-
|-
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH
|
|
|
|
|
|-
|-
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease||Jennelle Hodge||JH
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease||Jennelle Hodge||JH
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Maturation||Disease||Jennelle Hodge||JH
|    Acute Myeloid Leukemia (AML) with  Maturation||Disease||Jennelle Hodge||JH
|
|
|
|
|
|-
|-
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH
|
|
|
|
|
|-
|-
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH
|
|
|
|
|
|-
|-
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra||JH
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra||JH
|
|
|
|
|
|-
|-
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH
|
|
|
|
|
|-
|-
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH
|
|
|
|
|
|-
|-
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and  Jialing Huang||JH
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and  Jialing Huang||JH
|
|
|
|
|
|-
|-
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH
|
|
|
|
|
|-
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp||JH
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp||JH
|
|
|
|
|
|-
|-
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley||JH
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley||JH
|
|
|
|
|
|-
|-
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley||JH
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley||JH
|
|
|
|
|
|-
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH
|
|
|
|
|
|-
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH
|
|
|
|
|
|-
|-
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH
|
|
|
|
|
|-
|-
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH
|
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH
|
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH
|
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH
|
|
|
|
|
|-
|-
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease|| ||JH
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease|| ||JH
|
|
|
|
|
|-
|-
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease|| ||JH
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease|| ||JH
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
|
|
|
|
|
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||YA
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||YA
|
|
|
|
|
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
|
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA
|
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
|
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
|
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease|| ||YA
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease|| ||YA
|
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
|
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
|
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease|| ||YA
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease|| ||YA
|
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease|| ||YA
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease|| ||YA
|
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease|| ||YA
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease|| ||YA
|
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
|
|
|
|
|
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
|
|
|
|
|
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
|
|
|
|
|
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| ||SP
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease|| ||SP
|       Monoclonal B-cell  Lymphocytosis||Disease|| ||SP
|
|
|
|
|
|-
|-
|B-cell Prolymphocytic Leukemia||Disease|| ||SP
|B-cell Prolymphocytic Leukemia||Disease|| ||SP
|
|
|
|
|
|-
|-
|Splenic Marginal Zone Lymphoma||Disease|| ||SP
|Splenic Marginal Zone Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|Hairy Cell Leukemia||Disease|| ||SP
|Hairy Cell Leukemia||Disease|| ||SP
|
|
|
|
|
|-
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''|| ||SP
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|-
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease|| ||SP
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|    Hairy Cell Leukemia  Variant||Disease|| ||SP
|    Hairy Cell Leukemia  Variant||Disease|| ||SP
|
|
|
|
|
|-
|-
|Lymphoplasmacytic Lymphoma||Disease|| ||SP
|Lymphoplasmacytic Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|   Waldenstrom  Macroglobulinemia||Disease|| ||SP
|   Waldenstrom  Macroglobulinemia||Disease|| ||SP
|
|
|
|
|
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
|
|
|
|
|
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|-
|-
|    Mu Heavy Chain  Disease||Disease|| ||SP
|    Mu Heavy Chain  Disease||Disease|| ||SP
|
|
|
|
|
|-
|-
|   Gamma Heavy Chain  Disease||Disease|| ||SP
|   Gamma Heavy Chain  Disease||Disease|| ||SP
|
|
|
|
|
|-
|-
|    Alpha Heavy Chain  Disease||Disease|| ||SP
|    Alpha Heavy Chain  Disease||Disease|| ||SP
|
|
|
|
|
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''|| ||SP
|Plasma Cell Neoplasms||'''''Overview'''''|| ||SP
|
|
|
|
|
|-
|-
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease|| ||SP
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease|| ||SP
|
|
|
|
|
|-
|-
|    Plasma Cell Myeloma||Disease|| ||SP
|    Plasma Cell Myeloma||Disease|| ||SP
|
|
|
|
|
|-
|-
|    Plasma Cell Myeloma  Variants||Disease|| ||SP
|    Plasma Cell Myeloma  Variants||Disease|| ||SP
|
|
|
|
|
|-
|-
|    Plasmacytoma||Disease|| ||SP
|    Plasmacytoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|-
|-
|           Primary  Amyloidosis||Disease|| ||SP
|           Primary  Amyloidosis||Disease|| ||SP
|
|
|
|
|
|-
|-
|           Light Chain  and Heavy Chain Deposition Disease||Disease|| ||SP
|           Light Chain  and Heavy Chain Deposition Disease||Disease|| ||SP
|
|
|
|
|
|-
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|-
|-
|         POEMS Syndrome||Disease|| ||SP
|         POEMS Syndrome||Disease|| ||SP
|
|
|
|
|
|-
|-
|         TEMPI Syndrome||Disease|| ||SP
|         TEMPI Syndrome||Disease|| ||SP
|
|
|
|
|
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease|| ||SP
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease|| ||SP
|
|
|
|
|
|-
|-
|Nodal Marginal Zone Lymphoma||Disease|| ||SP
|Nodal Marginal Zone Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease|| ||SP
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|Follicular Lymphoma||Disease|| ||SP
|Follicular Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|    Testicular Follicular  Lymphoma||Disease|| ||SP
|    Testicular Follicular  Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|    In Situ Follicular  Neoplasia||Disease|| ||SP
|    In Situ Follicular  Neoplasia||Disease|| ||SP
|
|
|
|
|
|-
|-
|    Duodenal-Type  Follicular Lymphoma||Disease|| ||SP
|    Duodenal-Type  Follicular Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|Paediatric-Type Follicular Lymphoma||Disease|| ||SP
|Paediatric-Type Follicular Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP
|
|
|
|
|
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|Mantle Cell Lymphoma||Disease|| ||SP
|Mantle Cell Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease|| ||SP
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|    In Situ Mantle Cell  Neoplasia||Disease|| ||SP
|    In Situ Mantle Cell  Neoplasia||Disease|| ||SP
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC)
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC)
|
|
|
|
|
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
|
|
|
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
|
|
|
|
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
|
|
|
|
|
|-
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
|
|
|
|
|
|-
|-
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
|
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease|| ||GC
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease|| ||GC
|
|
|
|
|
|-
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
|
|
|
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease|| ||GC
|Lymphomatoid Granulomatosis||Disease|| ||GC
|
|
|
|
|
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
|
|
|
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
|
|
|
|
|
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
|
|
|
|
|
|-
|-
|Plasmablastic Lymphoma||Disease|| ||GC
|Plasmablastic Lymphoma||Disease|| ||GC
|
|
|
|
|
|-
|-
|Primary Effusion Lymphoma||Disease|| ||GC
|Primary Effusion Lymphoma||Disease|| ||GC
|
|
|
|
|
|-
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
|
|
|
|
|
|-
|-
|   Multicentric Castleman  Disease||Disease|| ||GC
|   Multicentric Castleman  Disease||Disease|| ||GC
|
|
|
|
|
|-
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|
|
|
|
|
|-
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
|
|
|
|
|
|-
|-
|Burkitt Lymphoma||Disease|| ||GC
|Burkitt Lymphoma||Disease|| ||GC
|
|
|
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
|
|
|
|
|
|-
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
|
|
|
|
|
|-
|-
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
|
|
|
|
|
|-
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|
|
|
|
|
|-
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Associate Editor??
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Associate Editor??
|
|
|
|
|
|-
|-
|T-cell Prolymphocytic Leukemia||Disease|| ||
|T-cell Prolymphocytic Leukemia||Disease|| ||
|
|
|
|
|
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease|| ||
|T-cell Large Granular Lymphocytic Leukemia||Disease|| ||
|
|
|
|
|
|-
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease|| ||
|Chronic Lymphoproliferative Disorder of NK Cells||Disease|| ||
|
|
|
|
|
|-
|-
|Aggressive NK-cell Leukemia||Disease|| ||
|Aggressive NK-cell Leukemia||Disease|| ||
|
|
|
|
|
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''|| ||
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease|| ||
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease|| ||
|
|
|
|
|
|-
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease|| ||
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease|| ||
|
|
|
|
|
|-
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease|| ||
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease|| ||
|
|
|
|
|
|-
|-
|    Severe Mosquito Bite  Allergy||Disease|| ||
|    Severe Mosquito Bite  Allergy||Disease|| ||
|
|
|
|
|
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease|| ||
|Adult T-cell Leukemia/Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| ||
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| ||
|
|
|
|
|
|-
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''|| ||
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease|| ||
|     Enteropathy-Associated T-cell Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease|| ||
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||
|
|
|
|
|
|-
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease|| ||
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease|| ||
|
|
|
|
|
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease|| ||
|Hepatosplenic T-cell Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| ||
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|Mycosis Fungoides||Disease|| ||
|Mycosis Fungoides||Disease|| ||
|
|
|
|
|
|-
|-
|Sézary Syndrome||Disease|| ||
|Sézary Syndrome||Disease|| ||
|
|
|
|
|
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''|| ||
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|-
|    Lymphomatoid  Papulosis||Disease|| ||
|    Lymphomatoid  Papulosis||Disease|| ||
|
|
|
|
|
|-
|-
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease|| ||
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| ||
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|-
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease|| ||
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| ||
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease|| ||
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| ||
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| ||
|
|
|
|
|
|-
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||
|
|
|
|
|
|-
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''|| ||
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|-
|     Angioimmunoblastic  T-cell Lymphoma||Disease|| ||
|     Angioimmunoblastic  T-cell Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|    Follicular T-cell  Lymphoma||Disease|| ||
|    Follicular T-cell  Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| ||
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| ||
|
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease|| ||
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease|| ||
|
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease|| ||
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease|| ||
|
|
|
|
|
|-
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease|| ||
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor??
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor??
|
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| ||
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| ||
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease|| ||
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease|| ||
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease|| ||
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease|| ||
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|-
|Lymphomas Associated with HIV Infection||Disease|| ||
|Lymphomas Associated with HIV Infection||Disease|| ||
|
|
|
|
|
|-
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
|
|
|
|
|
|-
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
|
|
|
|
|
|-
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|-
|          Monomorphic  B-cell PTLD||Disease|| ||
|          Monomorphic  B-cell PTLD||Disease|| ||
|
|
|
|
|
|-
|-
|          Monomorphic  T/NK-cell PTLD||Disease|| ||
|          Monomorphic  T/NK-cell PTLD||Disease|| ||
|
|
|
|
|
|-
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| ||
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| ||
|
|
|
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease|| ||
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease|| ||
|
|
|
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| ||
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|-
|Histiocytic Sarcoma||Disease|| ||
|Histiocytic Sarcoma||Disease|| ||
|
|
|
|
|
|-
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| ||
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|-
|   Langerhans Cell  Histiocytosis||Disease|| ||
|   Langerhans Cell  Histiocytosis||Disease|| ||
|
|
|
|
|
|-
|-
|   Langerhans Cell  Sarcoma||Disease|| ||
|   Langerhans Cell  Sarcoma||Disease|| ||
|
|
|
|
|
|-
|-
|Indeterminate Dendritic Cell Tumour||Disease|| ||
|Indeterminate Dendritic Cell Tumour||Disease|| ||
|
|
|
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease|| ||
|Interdigitating Dendritic Cell Sarcoma||Disease|| ||
|
|
|
|
|
|-
|-
|Follicular Dendritic Cell Sarcoma||Disease|| ||
|Follicular Dendritic Cell Sarcoma||Disease|| ||
|
|
|
|
|
|-
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| ||
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| ||
|
|
|
|
|
|-
|-
|Fibroblastic Reticular Cell Tumor||Disease|| ||
|Fibroblastic Reticular Cell Tumor||Disease|| ||
|
|
|
|
|
|-
|-
|Disseminated Juvenile Xanthogranuloma||Disease|| ||
|Disseminated Juvenile Xanthogranuloma||Disease|| ||
|
|
|
|
|
|-
|-
|Erdheim-Chester Disease||Disease|| ||
|Erdheim-Chester Disease||Disease|| ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|-
|-
| || || ||
| || || ||
|
|
|
|
|
|}
|}